<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36213964</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-1136</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Glia</Title><ISOAbbreviation>Glia</ISOAbbreviation></Journal><ArticleTitle>CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>350</StartPage><EndPage>365</EndPage><MedlinePgn>350-365</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/glia.24278</ELocationID><Abstract><AbstractText>Patient diversity and unknown disease cause are major challenges for drug development and clinical trial design for amyotrophic lateral sclerosis (ALS). Transgenic animal models do not adequately reflect the heterogeneity of ALS. Direct reprogramming of patient fibroblasts to neuronal progenitor cells and subsequent differentiation into patient astrocytes allows rapid generation of disease relevant cell types. Thus, this methodology can facilitate compound testing in a diverse genetic background resulting in a more representative population for therapeutic evaluation. Here, we used established co-culture assays with motor neurons and reprogrammed patient skin-derived astrocytes (iAs) to evaluate the effects of (SP-4-2)-[[2,2'-(1,2-dimethyl-1,2-ethanediylidene)bis[N-methylhydrazinecarbothioamidato-&#x3ba;N<sup>2</sup> ,&#x3ba;S]](2-)]-copper (CuATSM), currently in clinical trial for ALS in Australia. Pretreatment of iAs with CuATSM had a differential effect on neuronal survival following co-culture with healthy motor neurons. Using this assay, we identified responding and non-responding cell lines for both sporadic and familial ALS (mutant SOD1 and C9ORF72). Importantly, elevated mitochondrial respiration was the common denominator in all CuATSM-responders, a metabolic phenotype not observed in non-responders. Pre-treatment of iAs with CuATSM restored mitochondrial activity to levels comparable to healthy controls. Hence, this metabolic parameter might allow selection of patient subpopulations best suited for CuATSM treatment. Moreover, CuATSM might have additional therapeutic value for mitochondrial disorders. Enhanced understanding of patient-specific cellular and molecular profiles could help improve clinical trial design in the future.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. GLIA published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dennys</LastName><ForeName>Cassandra N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roussel</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigo</LastName><ForeName>Rochelle</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9683-6280</Identifier><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaojin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra Delgado</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartlaub</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saelim-Ector</LastName><ForeName>Asya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Will</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Mathematics Department, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heintzman</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolb</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Chemistry &amp; Pharmacology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular, Cellular &amp; Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckman</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Maria Clara</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5052-2101</Identifier><AffiliationInfo><Affiliation>Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular, Cellular &amp; Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, The Ohio State University Medical Center, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS107479</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glia</MedlineTA><NlmUniqueID>8806785</NlmUniqueID><ISSNLinking>0894-1491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000720849">CuATSM</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">CuATSM</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">responder</Keyword><Keyword MajorTopicYN="N">sporadic ALS</Keyword></KeywordList><CoiStatement>Stephen J. Kolb receives grant support from ALSA, NIH, and Novartis. He has received compensation for consultation from Novartis and Biogen. Joseph Beckman is an unpaid scientific advisor for Cassandra N. Dennys. Kathrin Meyer receives compensation for consultation from Alcyone Therapeutics and is part of their SAB. The therapeutic application described here were included in a patent application filed on August 31, 2020 (PCT/US2020/048779). Cassandra N. Dennys. Kathrin Meyer is listed as inventors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36213964</ArticleId><ArticleId IdType="pmc">PMC10092379</ArticleId><ArticleId IdType="doi">10.1002/glia.24278</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe, K. , Aoki, M. , Tsuji, S. , Itoyama, Y. , Sobue, G. , Togo, M. , Hamada, C. , Tanaka, M. , Akimoto, M. , Nakamura, K. , Takahashi, F. , Kondo, K. , Yoshino, H. , Abe, K. , Aoki, M. , Tsuji, S. , Itoyama, Y. , Sobue, G. , Togo, M. , &#x2026; Yoshino, H. (2017). Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double&#x2010;blind, placebo&#x2010;controlled trial. The Lancet Neurology, 16(7), 505&#x2013;512. 10.1016/S1474-4422(17)30115-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe, K. , Itoyama, Y. , Sobue, G. , Tsuji, S. , Aoki, M. , Doyu, M. , Hamada, C. , Kondo, K. , Yoneoka, T. , Akimoto, M. , &amp; Yoshino, H. (2014). Confirmatory double&#x2010;blind, parallel&#x2010;group, placebo&#x2010;controlled study of efficacy and safety of edaravone (MCI&#x2010;186) in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(7&#x2013;8), 610&#x2013;617. 10.3109/21678421.2014.959024</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959024</ArticleId><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe, K. , Pan, L. H. , Watanabe, M. , Konno, H. , Kato, T. , &amp; Itoyama, Y. (2016). Upregulation of protein&#x2010;tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurological Research, 19(2), 124&#x2013;128. 10.1080/01616412.1997.11740784</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.1997.11740784</ArticleId><ArticleId IdType="pubmed">9175139</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnoli, A. , Baldassarre, M. , Ruggieri, S. , Falaschi, P. , Urso, R. D. , &amp; Rocco, A. (1981). Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response. Journal of Neural Transmission, 51(1&#x2013;2), 123&#x2013;134. 10.1007/BF01664010</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01664010</ArticleId><ArticleId IdType="pubmed">7264625</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen, S. P. , Hall, B. , Castelli, L. M. , Francis, L. , Woof, R. , Siskos, A. P. , Kouloura, E. , Gray, E. , Thompson, A. G. , Talbot, K. , Higginbottom, A. , Myszczynska, M. , Allen, C. F. , Stopford, M. J. , Hemingway, J. , Bauer, C. S. , Webster, C. P. , De Vos, K. J. , Turner, M. R. , &#x2026; Shaw, P. J. (2019). Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain, 142(3), 586&#x2013;605. 10.1093/brain/awy353</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews, Z. B. , Horvath, B. , Barnstable, C. J. , Elseworth, J. , Yang, L. , Beal, M. F. , Roth, R. H. , Matthews, R. T. , &amp; Horvath, T. L. (2005). Uncoupling protein&#x2010;2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. Journal of Neuroscience, 25(1), 184&#x2013;191. 10.1523/JNEUROSCI.4269-04.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4269-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725213</ArticleId><ArticleId IdType="pubmed">15634780</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai, T. , Hasegawa, M. , Akiyama, H. , Ikeda, K. , Nonaka, T. , Mori, H. , Mann, D. , Tsuchiya, K. , Yoshida, M. , Hashizume, Y. , &amp; Oda, T. (2006). TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications, 351(3), 602&#x2013;611. 10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso, M. , Pozzi, S. , Tortarolo, M. , Fiordaliso, F. , Bisighini, C. , Pasetto, L. , Spaltro, G. , Lidonnici, D. , Gensano, F. , Battaglia, E. , Bendotti, C. , &amp; Bonetto, V. (2013). Mutant copper&#x2010;zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: Implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. Journal of Biological Chemistry, 288(22), 15699&#x2013;15711. 10.1074/jbc.M112.425066</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.425066</ArticleId><ArticleId IdType="pmc">PMC3668729</ArticleId><ArticleId IdType="pubmed">23592792</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal, M. F. , Ferrante, R. J. , Browne, S. E. , Matthews, R. T. , Kowall, N. W. , &amp; Brown, R. H. (1997). Increased 3&#x2010;nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Annals of Neurology, 42(4), 644&#x2013;654. 10.1002/ANA.410420416</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ANA.410420416</ArticleId><ArticleId IdType="pubmed">9382477</ArticleId></ArticleIdList></Reference><Reference><Citation>Beucher, S. (1992). The watershed transformation applied to image segmentation. Scanning Microscopy, 1992(6), 299&#x2013;314.</Citation></Reference><Reference><Citation>Bogdanov, M. , Brown, R. H. , Matson, W. , Smart, R. , Hayden, D. , O'Donnell, H. , Flint Beal, M. , &amp; Cudkowicz, M. (2000). Increased oxidative damage to DNA in ALS patients. Free Radical Biology and Medicine, 29(7), 652&#x2013;658. 10.1016/S0891-5849(00)00349-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00349-X</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco, D. A. , Morfini, G. , Karabacak, N. M. , Song, Y. , Gros&#x2010;Louis, F. , Pasinelli, P. , Goolsby, H. , Fontaine, B. A. , Lemay, N. , McKenna&#x2010;Yasek, D. , Frosch, M. P. , Agar, J. N. , Julien, J. P. , Brady, S. T. , &amp; Brown, R. H. (2010). Wild&#x2010;type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nature Neuroscience, 13(11), 1396&#x2013;1403. 10.1038/nn.2660</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley, D. , &amp; Roth, G. (2007). Adaptive thresholding using the integral image. Journal of Graphics Tools, 12(2), 13&#x2013;21. 10.1080/2151237x.2007.10129236</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2151237x.2007.10129236</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradski, G. (2000). The OpenCV library. Dr Dobb's Journal of Software Tools, 25, 120&#x2013;125.</Citation></Reference><Reference><Citation>Brand, M. D. (2016). Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radical Biology &amp; Medicine, 100, 14&#x2013;31. 10.1016/j.freeradbiomed.2016.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.04.001</ArticleId><ArticleId IdType="pubmed">27085844</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, R. H. , &amp; Al&#x2010;Chalabi, A. (2017). Amyotrophic lateral sclerosis. New England Journal of Medicine, 377(2), 162&#x2013;172. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Buades, A. , Coll, B. , &amp; Morel, J. M. (2005). A review of image denoising algorithms, with a new one. In Multiscale modeling and simulation (Vol. 4, pp. 490&#x2013;530). Society for Industrial and Applied Mathematics; 10.1137/040616024</Citation><ArticleIdList><ArticleId IdType="doi">10.1137/040616024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral&#x2010;Costa, J. V. , &amp; Kowaltowski, A. J. (2020). Neurological disorders and mitochondria. Molecular Aspects of Medicine, 71, 100826. 10.1016/J.MAM.2019.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MAM.2019.10.003</ArticleId><ArticleId IdType="pubmed">31630771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang, Y.&#x2010;C. , Lin, T.&#x2010;K. , Huang, H.&#x2010;Y. , Chang, W.&#x2010;N. , Liou, C.&#x2010;W. , Chen, S.&#x2010;D. , Chang, A. Y. , &amp; Chan, S. H. (2012). Peroxisome proliferator&#x2010;activated receptors &#x3b3;/mitochondrial uncoupling protein 2 signaling protects against seizure&#x2010;induced neuronal cell death in the hippocampus following experimental status epilepticus. Journal of Neuroinflammation, 9(1), 1&#x2013;18 10.1186/1742-2094-9-184</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-184</ArticleId><ArticleId IdType="pmc">PMC3444895</ArticleId><ArticleId IdType="pubmed">22849356</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement, A. M. , Nguyen, M. D. , Roberts, E. A. , Garcia, M. L. , Boill&#xe9;e, S. , Rule, M. , McMahon, A. P. , Doucette, W. , Siwek, D. , Ferrante, R. J. , Brown, R. H. , Julien, J. P. , Goldstein, L. S. B. , &amp; Cleveland, D. W. (2003). Wild&#x2010;type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science, 302(5642), 113&#x2013;117. 10.1126/science.1086071</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Date, R. , Siwek, T. , Barczewska, M. , Grabarczyk, L. , Sowa, M. , &amp; Jezierska&#x2010;Wozniak, K. (2018). Mesenchymal stem cell (MSC) transplantation in patients with amyotrophic lateral sclerosis (ALS): Is there a &#x201c;responder population&#x201d;? Journal of Neurology and Neuroscience, 9(3), 260 10.21767/2171-6625.1000260</Citation><ArticleIdList><ArticleId IdType="doi">10.21767/2171-6625.1000260</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennys, C. N. , Sierra&#x2010;Delgado, J. A. , Ray, S. S. , Hartlaub, A. M. , Roussel, F. S. , Rodriguez, Y. , &amp; Meyer, K. (2021). In vitro modeling for neurological diseases using direct conversion from fibroblasts to neuronal progenitor cells and differentiation into astrocytes. JoVE (Journal of Visualized Experiments), 172, e62016. 10.3791/62016</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/62016</ArticleId><ArticleId IdType="pubmed">34180877</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly, P. S. , Liddell, J. R. , Lim, S. , Paterson, B. M. , Cater, M. A. , Savva, M. S. , Mot, A. I. , James, J. L. , Trounce, I. A. , White, A. R. , &amp; Crouch, P. J. (2012). An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4&#x2010;methylthiosemicarbazonato)copperII. Proceedings of the National Academy of Sciences of the United States of America, 109(1), 47&#x2013;52. 10.1073/pnas.1116227108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1116227108</ArticleId><ArticleId IdType="pmc">PMC3252939</ArticleId><ArticleId IdType="pubmed">22173633</ArticleId></ArticleIdList></Reference><Reference><Citation>Factor, S. A. , Sanchez&#x2010;Ramos, J. R. , Weiner, W. J. , &amp; Ingenito, A. M. (1989). Efficacy of Sinemet CR4 in subgroups of patients with Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 52(1), 83&#x2013;88. 10.1136/jnnp.52.1.83</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.52.1.83</ArticleId><ArticleId IdType="pmc">PMC1032662</ArticleId><ArticleId IdType="pubmed">2709040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo, L. , Higginbottom, A. , Heath, P. R. , Barber, S. , Greenald, D. , Kirby, J. , &amp; Shaw, P. J. (2011). Dysregulation of astrocyte&#x2010;motoneuron cross&#x2010;talk in mutant superoxide dismutase 1&#x2010;related amyotrophic lateral sclerosis. Brain, 134(9), 2627&#x2013;2641. 10.1093/brain/awr193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr193</ArticleId><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante, R. J. , Browne, S. E. , Shinobu, L. A. , Bowling, A. C. , Baik, M. J. , MacGarvey, U. , Kowall, N. W. , Brown, R. H. , &amp; Beal, M. F. (1997). Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. Journal of Neurochemistry, 69(5), 2064&#x2013;2074. 10.1046/J.1471-4159.1997.69052064.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/J.1471-4159.1997.69052064.X</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzmaurice, P. S. , Shaw, I. C. , Kleiner, H. E. , Miller, R. T. , Monks, T. J. , Lau, S. S. , Mitchell, J. D. , &amp; Lynch, P. G. (1996). Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle &amp; Nerve, 19(6), 797&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, H. , Cai, J. , Clevers, H. , Fast, E. , Gray, S. , Greenberg, R. , Jain, M. K. , Ma, Q. , Qiu, M. , Rowitch, D. H. , Taylor, C. M. , &amp; Stiles, C. D. (2009). A genome&#x2010;wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. Journal of Neuroscience, 29(36), 11399&#x2013;11408. 10.1523/JNEUROSCI.0160-09.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0160-09.2009</ArticleId><ArticleId IdType="pmc">PMC2775518</ArticleId><ArticleId IdType="pubmed">19741146</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori, K. , Ishikawa, M. , Otomo, A. , Atsuta, N. , Nakamura, R. , Akiyama, T. , Hadano, S. , Aoki, M. , Saya, H. , Sobue, G. , &amp; Okano, H. (2018). Modeling sporadic ALS in iPSC&#x2010;derived motor neurons identifies a potential therapeutic agent. Nature Medicine, 24(10), 1579&#x2013;1589 10.1038/s41591-018-0140-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler, J. G. , Marosi, K. , Halpern, J. , &amp; Mattson, M. P. (2017). DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya. Alzheimer's and Dementia, 13(5), 582&#x2013;591. 10.1016/j.jalz.2016.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.08.001</ArticleId><ArticleId IdType="pmc">PMC5337177</ArticleId><ArticleId IdType="pubmed">27599210</ArticleId></ArticleIdList></Reference><Reference><Citation>Getreuer, P. (2013). ASurvey of Gaussian convolution algorithms. Image Processing Online, 3, 286&#x2013;310. 10.5201/ipol.2013.87</Citation><ArticleIdList><ArticleId IdType="doi">10.5201/ipol.2013.87</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet&#x2010;Phillips, A. M. , Hester, M. E. , Miranda, C. J. , Meyer, K. , Braun, L. , Frakes, A. , Song, S. , Likhite, S. , Murtha, M. J. , Foust, K. D. , Rao, M. , Eagle, A. , Kammesheidt, A. , Christensen, A. , Mendell, J. R. , Burghes, A. H. M. , &amp; Kaspar, B. K. (2011). Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nature Biotechnology, 29(9), 824&#x2013;828. 10.1038/nbt.1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines, B. A. , Mehta, S. L. , Pratt, S. M. , Warden, C. H. , &amp; Li, P. A. (2010). Deletion of mitochondrial uncoupling protein&#x2010;2 increases ischemic brain damage after transient focal ischemia by altering gene expression patterns and enhancing inflammatory cytokines. Journal of Cerebral Blood Flow &amp; Metabolism, 30(11), 1825. 10.1038/JCBFM.2010.52</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/JCBFM.2010.52</ArticleId><ArticleId IdType="pmc">PMC2948647</ArticleId><ArticleId IdType="pubmed">20407461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hass, D. T. , &amp; Barnstable, C. J. (2016). Uncoupling protein 2 in the glial response to stress: Implications for neuroprotection. Neural Regeneration Research, 11(8), 1197&#x2013;1200 10.4103/1673-5374.189159</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.189159</ArticleId><ArticleId IdType="pmc">PMC5020804</ArticleId><ArticleId IdType="pubmed">27651753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton, J. B. , Mercer, S. W. , Lim, N. K. H. , Faux, N. G. , Buncic, G. , Beckman, J. S. , Roberts, B. R. , Donnelly, P. S. , White, A. R. , &amp; Crouch, P. J. (2017). CuII (atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord. Scientific Reports, 7(January), 1&#x2013;11. 10.1038/srep42292</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42292</ArticleId><ArticleId IdType="pmc">PMC5304223</ArticleId><ArticleId IdType="pubmed">28205575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, P. , Liu, H.&#x2010;F. , Ho, J. , Zhang, W.&#x2010;Y. , Chu, A. , Kwok, K. , Ge, X. , Chan, K.&#x2010;H. , Ramsden, D. , &amp; Ho, S.&#x2010;L. (2009). Mitochondrial uncoupling protein&#x2010;2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells. Neurotoxicity Research, 17(4), 332&#x2013;343. 10.1007/s12640-009-9109-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-009-9109-y</ArticleId><ArticleId IdType="pmc">PMC2946553</ArticleId><ArticleId IdType="pubmed">19763737</ArticleId></ArticleIdList></Reference><Reference><Citation>Honjo, Y. , Kaneko, S. , Ito, H. , Horibe, T. , Nagashima, M. , Nakamura, M. , Fujita, K. , Takahashi, R. , Kusaka, H. , &amp; Kawakami, K. (2011). Protein disulfide isomerase&#x2010;immunopositive inclusions in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12(6), 444&#x2013;450. 10.3109/17482968.2011.594055</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.594055</ArticleId><ArticleId IdType="pubmed">21745122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, L. W. , Villemagne, V. L. , Cheng, L. , Sherratt, N. A. , Ayton, S. , White, A. R. , Crouch, P. J. , Lim, S. C. , Leong, S. L. , Wilkins, S. , George, J. , Roberts, B. R. , Pham, C. L. L. , Liu, X. , Chiu, F. C. K. , Shackleford, D. M. , Powell, A. K. , Masters, C. L. , Bush, A. I. , &#x2026; Barnham, K. J. (2012). The hypoxia imaging agent cu ii(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. Journal of Experimental Medicine, 209(4), 837&#x2013;854. 10.1084/jem.20112285</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20112285</ArticleId><ArticleId IdType="pmc">PMC3328361</ArticleId><ArticleId IdType="pubmed">22473957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara, Y. , Nobukuni, K. , Takata, H. , &amp; Hayabara, T. (2013). Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn&#x2010;superoxide dismutase mutation. Neurological Research, 27(1), 105&#x2013;108. 10.1179/016164105X18430</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164105X18430</ArticleId><ArticleId IdType="pubmed">15829169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa, M. , Okazawa, H. , Arakawa, K. , Kudo, T. , Kimura, H. , Fujibayashi, Y. , Kuriyama, M. , &amp; Yoneda, M. (2009). PET imaging of redox and energy states in stroke&#x2010;like episodes of MELAS. Mitochondrion, 9(2), 144&#x2013;148. 10.1016/j.mito.2009.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2009.01.011</ArticleId><ArticleId IdType="pubmed">19460295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa, M. , Okazawa, H. , Kudo, T. , Kuriyama, M. , Fujibayashi, Y. , &amp; Yoneda, M. (2011). Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nuclear Medicine and Biology, 38(7), 945&#x2013;951. 10.1016/j.nucmedbio.2011.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2011.02.016</ArticleId><ArticleId IdType="pubmed">21982566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa, M. , Okazawa, H. , Tsujikawa, T. , Matsunaga, A. , Yamamura, O. , Mori, T. , Hamano, T. , Kiyono, Y. , Nakamoto, Y. , &amp; Yoneda, M. (2015). Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study. Neurology, 84(20), 2033&#x2013;2039. 10.1212/WNL.0000000000001588</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001588</ArticleId><ArticleId IdType="pubmed">25904686</ArticleId></ArticleIdList></Reference><Reference><Citation>Korde, A. S. , Pettigrew, L. C. , Craddock, S. D. , &amp; Maragos, W. F. (2005). The mitochondrial uncoupler 2,4&#x2010;dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia. Journal of Neurochemistry, 94(6), 1676&#x2013;1684. 10.1111/J.1471-4159.2005.03328.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1471-4159.2005.03328.X</ArticleId><ArticleId IdType="pubmed">16045446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, R. , Amruthanjali, T. , Singothu, S. , Singh, S. B. , &amp; Bhandari, V. (2022). Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder. Biomedicine &amp; Pharmacotherapy, 147, 112656. 10.1016/j.biopha.2022.112656</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112656</ArticleId><ArticleId IdType="pubmed">35091238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo, M. T. H. , Beckman, J. S. , &amp; Shaw, C. A. (2019). Neuroprotective effect of CuATSM on neurotoxin&#x2010;induced motor neuron loss in an ALS mouse model. Neurobiology of Disease, 130, 104495. 10.1016/j.nbd.2019.104495</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104495</ArticleId><ArticleId IdType="pubmed">31181282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, A. , Hirabayashi, Y. , Kwon, S. K. , Lewis, T. L. , &amp; Polleux, F. (2018). Emerging roles of mitochondria in synaptic transmission and neurodegeneration. Current Opinion in Physiology, 3, 82&#x2013;93. 10.1016/J.COPHYS.2018.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.COPHYS.2018.03.009</ArticleId><ArticleId IdType="pmc">PMC6178220</ArticleId><ArticleId IdType="pubmed">30320242</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh, P. N. , Anderton, B. H. , Dodson, A. , Gallo, J. M. , Swash, M. , &amp; Power, D. M. (1988). Ubiquitin deposits in anterior horn cells in motor neurone disease. Neuroscience Letters, 93(2&#x2013;3), 197&#x2013;203. 10.1016/0304-3940(88)90081-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(88)90081-X</ArticleId><ArticleId IdType="pubmed">2853844</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh, P. N. , Whitwell, H. , Garofalo, O. , Buller, J. , Swash, M. , Martin, J. E. , Gallo, J. M. , Weller, R. O. , &amp; Anderton, B. H. (1991). Ubiquitin&#x2010;immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: Morphology, distribution, and specificity. Brain, 114(2), 775&#x2013;788. 10.1093/brain/114.2.775</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/114.2.775</ArticleId><ArticleId IdType="pubmed">1646064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, L. , Jackson&#x2010;Lewis, V. , Wong, L. C. , Shui, G. H. , Goh, A. X. H. , Kesavapany, S. , Jenner, A. M. , Fivaz, M. , Przedborski, S. , &amp; Wenk, M. R. (2012). Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease. Cell Death and Differentiation, 19(3), 416&#x2013;427. 10.1038/cdd.2011.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2011.105</ArticleId><ArticleId IdType="pmc">PMC3278725</ArticleId><ArticleId IdType="pubmed">21818119</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum, B. , Mavel, S. , Coque, E. , Patin, F. , Vourc'h, P. , Marouillat, S. , Nadal&#x2010;Desbarats, L. , Emond, P. , Corcia, P. , Andres, C. R. , Raoul, C. , &amp; Blasco, H. (2017). Wildtype motoneurons, ALS&#x2010;linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia, 65(4), 592&#x2013;605. 10.1002/glia.23114</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa, S. , Leigh, P. N. , King, A. , Jones, E. , Steele, J. C. , Bodi, I. , Shaw, C. E. , Hortobagyi, T. , &amp; Al&#x2010;Sarraj, S. (2009). TDP&#x2010;43 is consistently co&#x2010;localized with ubiquitinated inclusions in sporadic and guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology, 29(6), 672&#x2013;683. 10.1111/j.1440-1789.2009.01029.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01029.x</ArticleId><ArticleId IdType="pubmed">19496940</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori, P. , &amp; Van Damme, P. (2020). Amyotrophic lateral sclerosis: A clinical review. In European journal of neurology (Vol. 27, pp. 1918&#x2013;1929). Blackwell Publishing Ltd; 10.1111/ene.14393</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiasson, G. , Shamloo, M. , Gido, G. , Mathi, K. , Tomasevic, G. , Yi, S. , Warden, C. H. , Castilho, R. F. , Melcher, T. , Gonzalez&#x2010;Zulueta, M. , Nikolich, K. , &amp; Wieloch, T. (2003). Uncoupling protein&#x2010;2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nature Medicine, 9(8), 1062&#x2013;1068 10.1038/nm903</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm903</ArticleId><ArticleId IdType="pubmed">12858170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson, M. P. , Gleichmann, M. , &amp; Cheng, A. (2008). Mitochondria in neuroplasticity and neurological disorders. Neuron, 60(5), 748. 10.1016/J.NEURON.2008.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2008.10.010</ArticleId><ArticleId IdType="pmc">PMC2692277</ArticleId><ArticleId IdType="pubmed">19081372</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies, F. M. (2002). Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain, 125(7), 1522&#x2013;1533. 10.1093/brain/awf167</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf167</ArticleId><ArticleId IdType="pubmed">12077002</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer, K. , Ferraiuolo, L. , Miranda, C. J. , Likhite, S. , McElroy, S. , Renusch, S. , Ditsworth, D. , Lagier&#x2010;Tourenne, C. , Smith, R. A. , Ravits, J. , Burghes, A. H. , Shaw, P. J. , Cleveland, D. W. , Kolb, S. J. , &amp; Kaspar, B. K. (2014). Direct conversion of patient fibroblasts demonstrates non&#x2010;cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proceedings of the National Academy of Sciences of the United States of America, 111(2), 829&#x2013;832. 10.1073/pnas.1314085111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. J. , Bouchard, J. P. , Duquette, P. , Eisen, A. , Gelinas, D. , Harati, Y. , Munsat, L. , Powe, L. , Rothstein, J. , Salzman, P. , &amp; Sufit, R. L. (1996). Clinical trials of riluzole in patients with ALS. Neurology, 47(2), S86&#x2013;S92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8858057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno, Y. , Amari, M. , Takatama, M. , Aizawa, H. , Mihara, B. , &amp; Okamoto, K. (2006). Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis. Acta Neuropathologica, 112, 597&#x2013;603. 10.1007/s00401-006-0122-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0122-4</ArticleId><ArticleId IdType="pubmed">16896902</ArticleId></ArticleIdList></Reference><Reference><Citation>Montesanto, A. , Crocco, P. , Anfossi, M. , Smirne, N. , Puccio, G. , Colao, R. , Maletta, R. , Passarino, G. , Bruni, A. C. , &amp; Rose, G. (2016). The genetic variability of UCP4 affects the individual susceptibility to late&#x2010;onset Alzheimer's disease and modifies the disease's risk in apoe&#x2010; &#x3f5; 4 carriers. Journal of Alzheimer's Disease, 51(4), 1265&#x2013;1274. 10.3233/JAD-150993</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150993</ArticleId><ArticleId IdType="pubmed">26923023</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello, G. , Guarnaccia, M. , Spampinato, A. G. , Salomone, S. , D'Agata, V. , Conforti, F. L. , Aronica, E. , &amp; Cavallaro, S. (2019). Integrative multi&#x2010;omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Scientific Reports, 9(1), 1&#x2013;18 10.1038/s41598-019-46355-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46355-w</ArticleId><ArticleId IdType="pmc">PMC6620285</ArticleId><ArticleId IdType="pubmed">31292500</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder, D. W. , Kurland, L. T. , Offord, K. P. , &amp; Beard, M. (1986). Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology, 36(4), 511&#x2013;517. 10.1212/WNL.36.4.511</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.36.4.511</ArticleId><ArticleId IdType="pubmed">3960325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai, M. , Re, D. B. , Nagata, T. , Chalazonitis, A. , Jessell, T. M. , Wichterle, H. , &amp; Przedborski, S. (2007). Astrocytes expressing ALS&#x2010;linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neuroscience, 10(5), 615&#x2013;622. 10.1038/nn1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan, S. V. , Dave, K. R. , Saul, I. , &amp; Perez&#x2010;Pinzon, M. A. (2015). Resveratrol preconditioning protects against cerebral ischemic injury via nuclear erythroid 2&#x2013;related factor 2. Stroke, 46(6), 1626&#x2013;1632. 10.1161/STROKEAHA.115.008921</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.008921</ArticleId><ArticleId IdType="pmc">PMC4442036</ArticleId><ArticleId IdType="pubmed">25908459</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M. , Sampathu, D. M. , Kwong, L. K. , Truax, A. C. , Micsenyi, M. C. , Chou, T. T. , Bruce, J. , Schuck, T. , Grossman, M. , Clark, C. M. , McCluskey, L. F. , Miller, B. L. , Masliah, E. , Mackenzie, I. R. , Feldman, H. , Feiden, W. , Kretzschmar, H. A. , Trojanowski, J. Q. , &amp; Lee, V. M. Y. (2006). Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto, K. , Mizuno, Y. , &amp; Fujita, Y. (2008). Bunina bodies in amyotrophic lateral sclerosis. Neuropathology, 28, 109&#x2013;115. 10.1111/j.1440-1789.2007.00873.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2007.00873.x</ArticleId><ArticleId IdType="pubmed">18069968</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadeas, S. T. , Kraig, S. E. , O'Banion, C. , Lepore, A. C. , &amp; Maragakis, N. J. (2011). Astrocytes carrying the superoxide dismutase 1 (SOD1 G93A) mutation induce wild&#x2010;type motor neuron degeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America, 108(43), 17803&#x2013;17808. 10.1073/pnas.1103141108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103141108</ArticleId><ArticleId IdType="pmc">PMC3203804</ArticleId><ArticleId IdType="pubmed">21969586</ArticleId></ArticleIdList></Reference><Reference><Citation>Perreten Lambert, H. , Zenger, M. , Azarias, G. , Chatton, J.&#x2010;Y. , Magistretti, P. J. , &amp; Lengacher, S. (2014). Control of mitochondrial pH by uncoupling protein 4 in astrocytes promotes neuronal survival. The Journal of Biological Chemistry, 289(45), 31014&#x2013;31028. 10.1074/jbc.M114.570879</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.570879</ArticleId><ArticleId IdType="pmc">PMC4223307</ArticleId><ArticleId IdType="pubmed">25237189</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestoni, J. C. , Plati, S. K. , Valdivia Camacho, O. D. , Fuse, M. A. , Onatunde, M. , Sparrow, N. A. , Karajannis, M. A. , Fern&#xe1;ndez&#x2010;Valle, C. , &amp; Franco, M. C. (2019). Peroxynitrite supports a metabolic reprogramming in merlin&#x2010;deficient Schwann cells and promotes cell survival. Journal of Biological Chemistry, 294(30), 11354&#x2013;11368. 10.1074/jbc.RA118.007152</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007152</ArticleId><ArticleId IdType="pmc">PMC6663865</ArticleId><ArticleId IdType="pubmed">31171721</ArticleId></ArticleIdList></Reference><Reference><Citation>Piao, Y. S. , Wakabayashi, K. , Kakita, A. , Yamada, M. , Hayashi, S. , Morita, T. , Ikuta, F. , Oyanagi, K. , &amp; Takahashi, H. (2003). Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathology, 13(1), 10&#x2013;22. 10.1111/j.1750-3639.2003.tb00002.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2003.tb00002.x</ArticleId><ArticleId IdType="pmc">PMC8095891</ArticleId><ArticleId IdType="pubmed">12580541</ArticleId></ArticleIdList></Reference><Reference><Citation>Re, D. B. , Le Verche, V. , Yu, C. , Amoroso, M. W. , Politi, K. A. , Phani, S. , Ikiz, B. , Hoffmann, L. , Koolen, M. , Nagata, T. , Papadimitriou, D. , Nagy, P. , Mitsumoto, H. , Kariya, S. , Wichterle, H. , Henderson, C. E. , &amp; Przedborski, S. (2014). Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron, 81(5), 1001&#x2013;1008. 10.1016/j.neuron.2014.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich, K. A. , Roggenbuck, J. , &amp; Kolb, S. J. (2020). Searching far and genome&#x2010;wide: The relevance of association studies in amyotrophic lateral sclerosis. Frontiers in Neuroscience, 14, 14. 10.3389/FNINS.2020.603023</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNINS.2020.603023</ArticleId><ArticleId IdType="pmc">PMC7873947</ArticleId><ArticleId IdType="pubmed">33584177</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi, F. , Motti, D. , Ferraiuolo, L. , &amp; Kaspar, B. K. (2017). High content analysis in amyotrophic lateral sclerosis. In Molecular and cellular neuroscience (Vol. 80, pp. 180&#x2013;191). Academic Press Inc.. 10.1016/j.mcn.2016.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.12.001</ArticleId><ArticleId IdType="pmc">PMC5393940</ArticleId><ArticleId IdType="pubmed">27965018</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, B. R. , Lim, N. K. H. , McAllum, E. J. , Donnelly, P. S. , Hare, D. J. , Doble, P. A. , Turner, B. J. , Price, K. A. , Lim, S. C. , Paterson, B. M. , Hickey, J. L. , Rhoads, T. W. , Williams, J. R. , Kanninen, K. M. , Hung, L. W. , Liddell, J. R. , Grubman, A. , Monty, J. F. , Llanos, R. M. , &#x2026; Crouch, P. J. (2014). Oral treatment with CuII(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience, 34(23), 8021&#x2013;8031. 10.1523/JNEUROSCI.4196-13.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4196-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>Roggenbuck, J. , &amp; Fong, J. C. (2020). Genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: Impact on clinical management. Clinics in Laboratory Medicine, 40(3), 271&#x2013;287. 10.1016/J.CLL.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CLL.2020.05.002</ArticleId><ArticleId IdType="pubmed">32718499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein, J. D. , Dykes&#x2010;Hoberg, M. , Pardo, C. A. , Bristol, L. A. , Jin, L. , Kuncl, R. W. , Kanai, Y. , Hediger, M. A. , Wang, Y. , Schielke, J. P. , &amp; Welty, D. F. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron, 16(3), 675&#x2013;686. 10.1016/s0896-6273(00)80086-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80086-0</ArticleId><ArticleId IdType="pubmed">8785064</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary, E. R. , Sison, S. L. , &amp; Ebert, A. D. (2018). Modeling protein aggregation and the heat shock response in ALS iPSC&#x2010;derived motor neurons. Frontiers in Neuroscience, 12(Feb). 10.3389/fnins.2018.00086</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00086</ArticleId><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra, H. M. (1967a). Morphologie mathematique et granulometries en place. Annales Des Mines, XII(2), 768&#x2013;782.</Citation></Reference><Reference><Citation>Serra, H. M. (1967b). Morphologie mathematique et granulometries en place. Annales Des Mines, XI(1), 736&#x2013;753.</Citation></Reference><Reference><Citation>Shibata, N. , Nagai, R. , Uchida, K. , Horiuchi, S. , Yamada, S. , Hirano, A. , Kawaguchi, M. , Yamamoto, T. , Sasaki, S. , &amp; Kobayashi, M. (2001). Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Research, 917(1), 97&#x2013;104. 10.1016/S0006-8993(01)02926-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(01)02926-2</ArticleId><ArticleId IdType="pubmed">11602233</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigeta, M. , Nishikawa, Y. , Shimizu, M. , Usui, M. , Hyoki, K. , &amp; Kawamuro, Y. (1993). Responders and non&#x2010;responders to bifemelane hydrochloride in alzheimer&#x2010;type and multi&#x2010;infarct dementia. International Clinical Psychopharmacology, 8(2), 109&#x2013;114. 10.1097/00004850-199300820-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004850-199300820-00005</ArticleId><ArticleId IdType="pubmed">8345159</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, E. P. , Henry, Y. K. , Henkel, J. S. , Smith, R. G. , &amp; Appel, S. H. (2004). Increased lipid peroxidation in sera of ALS patients. Neurology, 62(10), 1758&#x2013;1765. 10.1212/WNL.62.10.1758</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirangelo, I. , &amp; Iannuzzi, C. (2017). The role of metal binding in the amyotrophic lateral sclerosis&#x2010;related aggregation of copper&#x2010;zinc superoxide dismutase. Molecules, 22(9), 1&#x2013;13. 10.3390/molecules22091429</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22091429</ArticleId><ArticleId IdType="pmc">PMC6151412</ArticleId><ArticleId IdType="pubmed">28850080</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, R. G. , Henry, Y. K. , Mattson, M. P. , &amp; Appel, S. H. (1998). Presence of 4&#x2010;hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Annals of Neurology, 44(4), 696&#x2013;699. 10.1002/ANA.410440419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ANA.410440419</ArticleId><ArticleId IdType="pubmed">9778272</ArticleId></ArticleIdList></Reference><Reference><Citation>Soon, C. P. W. , Donnelly, P. S. , Turner, B. J. , Hung, L. W. , Crouch, P. J. , Sherratt, N. A. , Tan, J.&#x2010;L. , Lim, N. K.&#x2010;H. , Lam, L. , Bica, L. , Lim, S. , Hickey, J. L. , Morizzi, J. , Powell, A. , Finkelstein, D. I. , Culvenor, J. G. , Masters, C. L. , Duce, J. , White, A. R. , &#x2026; Li, Q.&#x2010;X. (2011). Diacetylbis(N(4)&#x2010;methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite&#x2010;induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. The Journal of Biological Chemistry, 286(51), 44035&#x2013;44044. 10.1074/jbc.M111.274407</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274407</ArticleId><ArticleId IdType="pmc">PMC3243559</ArticleId><ArticleId IdType="pubmed">22033929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan, P. G. , Dub&#xe9;, C. , Dorenbos, K. , Steward, O. , &amp; Baram, T. Z. (2003). Mitochondrial uncoupling protein&#x2010;2 protects the immature brain from excitotoxic neuronal death. Annals of Neurology, 53(6), 711. 10.1002/ANA.10543</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ANA.10543</ArticleId><ArticleId IdType="pmc">PMC2930774</ArticleId><ArticleId IdType="pubmed">12783416</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei, K. , Watanabe, K. , Yuki, S. , Akimoto, M. , Sakata, T. , &amp; Palumbo, J. (2017). Edaravone and its clinical development for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18, 5&#x2013;10. 10.1080/21678421.2017.1353101</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1353101</ArticleId><ArticleId IdType="pubmed">28872907</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, C. F. , Eguchi, H. , Tagawa, A. , Onodera, O. , Iwasaki, T. , Tsujino, A. , Nishizawa, M. , Kakita, A. , &amp; Takahashi, H. (2007). TDP&#x2010;43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathologica, 113(5), 535&#x2013;542. 10.1007/s00401-007-0206-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0206-9</ArticleId><ArticleId IdType="pubmed">17333220</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneri, A. , McGeown, W. , &amp; Shanks, M. (2009). Responders to ChEI treatment of Alzheimers disease show restitution of normal regional cortical activation. Current Alzheimer Research, 6(2), 97&#x2013;111. 10.2174/156720509787602933</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720509787602933</ArticleId><ArticleId IdType="pubmed">19355844</ArticleId></ArticleIdList></Reference><Reference><Citation>Walz, W. , &amp; Mukerji, S. (1988). Lactate release from cultured astrocytes and neurons: A comparison. Glia, 1(6), 366&#x2013;370. 10.1002/glia.440010603</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440010603</ArticleId><ArticleId IdType="pubmed">2976396</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, J. R. , Trias, E. , Beilby, P. R. , Lopez, N. I. , Labut, E. M. , Bradford, C. S. , Roberts, B. R. , McAllum, E. J. , Crouch, P. J. , Rhoads, T. W. , Pereira, C. , Son, M. , Elliott, J. L. , Franco, M. C. , Est&#xe9;vez, A. G. , Barbeito, L. , &amp; Beckman, J. S. (2016). Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co&#x2010;expressing the copper&#x2010;chaperone&#x2010;for&#x2010;SOD. Neurobiology of Disease, 89, 1&#x2013;9. 10.1016/j.nbd.2016.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.01.020</ArticleId><ArticleId IdType="pmc">PMC4785045</ArticleId><ArticleId IdType="pubmed">26826269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka, K. , Chun, S. J. , Boillee, S. , Fujimori&#x2010;Tonou, N. , Yamashita, H. , Gutmann, D. H. , Takahashi, R. , Misawa, H. , &amp; Cleveland, D. W. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11(3), 251&#x2013;253. 10.1038/nn2047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii, Y. , Yoneda, M. , Ikawa, M. , Furukawa, T. , Kiyono, Y. , Mori, T. , Yoshii, H. , Oyama, N. , Okazawa, H. , Saga, T. , &amp; Fujibayashi, Y. (2012). Radiolabeled cu&#x2010;ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: Studies with mitochondrial DNA&#x2010;less &#x3c1;0 cells and cybrids carrying MELAS mitochondrial DNA mutation. Nuclear Medicine and Biology, 39(2), 177&#x2013;185. 10.1016/j.nucmedbio.2011.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2011.08.008</ArticleId><ArticleId IdType="pubmed">22033022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>